Literature DB >> 31701950

Revised wording to the National Advisory Committee on Immunization (NACI) recommendation for Live Attenuated Influenza Vaccine (LAIV) in healthy children and adolescents 2-17 years of age.

.   

Abstract

Entities:  

Year:  2013        PMID： 31701950      PMCID： PMC6802441          DOI： 10.14745/ccdr.v39i00a04r

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  3 in total

1.  Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Authors:  Douglas M Fleming; Pietro Crovari; Ulrich Wahn; Timo Klemola; Yechiel Schlesinger; Alexangros Langussis; Knut Øymar; Maria Luz Garcia; Alain Krygier; Herculano Costa; Ulrich Heininger; Jean-Louis Pregaldien; Sheau-Mei Cheng; Jonathan Skinner; Ahmad Razmpour; Melanie Saville; William C Gruber; Bruce Forrest
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

2.  Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Authors:  Shai Ashkenazi; Andre Vertruyen; Javier Arístegui; Susanna Esposito; David Douglas McKeith; Timo Klemola; Jiri Biolek; Joachim Kühr; Tadeusz Bujnowski; Daniel Desgrandchamps; Sheau-Mei Cheng; Jonathan Skinner; William C Gruber; Bruce D Forrest
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

3.  Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.

Authors:  Robert B Belshe; Seth L Toback; Tingting Yi; Christopher S Ambrose
Journal:  Influenza Other Respir Viruses       Date:  2010-05-01       Impact factor: 4.380
  3 in total
  1 in total

1.  Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.

Authors:  W Vaudry; R Stirling
Journal:  Can Commun Dis Rep       Date:  2017-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.